BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1025 related articles for article (PubMed ID: 30083944)

  • 1. Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation for aortic stenosis using Medtronic new generation self-expanding CoreValve Evolut R.
    Kaneko H; Hoelschermann F; Seifert M; Tambor G; Okamoto M; Moeller V; Neuss M; Butter C
    Heart Vessels; 2019 Feb; 34(2):360-367. PubMed ID: 30083944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter Heart Valve Selection and Permanent Pacemaker Implantation in Patients With Pre-Existent Right Bundle Branch Block.
    van Gils L; Tchetche D; Lhermusier T; Abawi M; Dumonteil N; Rodriguez Olivares R; Molina-Martin de Nicolas J; Stella PR; Carrié D; De Jaegere PP; Van Mieghem NM
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28258051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Matched Outcome of Evolut-R vs CoreValve Transcatheter Aortic Valve Implantation.
    Landes U; Bental T; Barsheshet A; Assali A; Vaknin Assa H; Levi A; Orvin K; Kornowski R
    J Invasive Cardiol; 2017 Feb; 29(2):69-74. PubMed ID: 28145874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrioventricular Conduction Changes After CoreValve Transcatheter Aortic Valve Implantation.
    López-Aguilera J; Segura Saint-Gerons JM; Mazuelos Bellido F; Suárez de Lezo J; Ojeda Pineda S; Pan Álvarez-Ossorio M; Romero Moreno MÁ; Pavlovic D; Espejo Pérez S; Suárez de Lezo J
    Rev Esp Cardiol (Engl Ed); 2016 Jan; 69(1):28-36. PubMed ID: 26215663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the repositionable Evolut R CoreValve system on the need for a permanent pacemaker after transcatheter aortic valve implantation in patients with severe aortic stenosis.
    Ojeda S; Hidalgo F; Romero M; Mazuelos F; Suárez de Lezo J; Martín E; Lostalo A; Luque A; González R; Fernández A; López-Aguilera J; Segura J; Guerrero N; Pan M
    Catheter Cardiovasc Interv; 2020 Mar; 95(4):783-790. PubMed ID: 31062927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the occurrence of new conduction abnormalities after transcatheter aortic valve implantation.
    van der Boon RM; Houthuizen P; Urena M; Poels TT; van Mieghem NM; Brueren GR; Altintas S; Nuis RJ; Serruys PW; van Garsse LA; van Domburg RT; Cabau JR; de Jaegere PP; Prinzen FW
    Catheter Cardiovasc Interv; 2015 Apr; 85(5):E144-52. PubMed ID: 25504891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Assessment of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation in Patients With Preexisting Right Bundle Branch Block.
    Sugiyama Y; Miyashita H; Yokoyama H; Ochiai T; Shishido K; Jalanko M; Yamanaka F; Vähäsilta T; Saito S; Laine M; Moriyama N
    Am J Cardiol; 2024 Feb; 213():151-160. PubMed ID: 38103766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of three different new generation transcatheter aortic valve prostheses.
    Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of transcatheter aortic valve implantation-related heart block in self-expandable Medtronic CoreValve and balloon-expandable Edwards valves.
    Liang M; Devlin G; Pasupati S
    J Invasive Cardiol; 2012 Apr; 24(4):173-6. PubMed ID: 22477754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence rate and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis.
    Calvi V; Conti S; Pruiti GP; Capodanno D; Puzzangara E; Tempio D; Di Grazia A; Ussia GP; Tamburino C
    J Interv Card Electrophysiol; 2012 Aug; 34(2):189-95. PubMed ID: 22119855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of Left Ventricular Fractional Shortening to Needfor Permanent Pacemaker After Transcatheter AorticValve Implantation.
    Orvin K; Herzberg H; Golovchiner G; Kadmon E; Omelchenko A; Assali A; Vaknin-Assa H; Sagie A; Shapira Y; Vaturi M; Kornowski R; Barsheshet A
    Am J Cardiol; 2018 Sep; 122(5):833-837. PubMed ID: 30032864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of permanent pacemaker requirement after transcatheter aortic valve implantation with a self-expanding bioprosthesis.
    Ferreira ND; Caeiro D; Adão L; Oliveira M; Gonçalves H; Ribeiro J; Teixeira M; Albuquerque A; Primo J; Braga P; Simões L; Ribeiro VG
    Pacing Clin Electrophysiol; 2010 Nov; 33(11):1364-72. PubMed ID: 20723083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Highly Predictive Risk Model for Pacemaker Implantation After TAVR.
    Maeno Y; Abramowitz Y; Kawamori H; Kazuno Y; Kubo S; Takahashi N; Mangat G; Okuyama K; Kashif M; Chakravarty T; Nakamura M; Cheng W; Friedman J; Berman D; Makkar RR; Jilaihawi H
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1139-1147. PubMed ID: 28412434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Real-World Comparison of 1-Year Survival and Expenditures for Transcatheter Aortic Valve Replacements: SAPIEN 3 Versus CoreValve Versus Evolut R.
    Fukuda H; Kiyohara K; Sato D; Kitamura T; Kodera S
    Value Health; 2021 Apr; 24(4):497-504. PubMed ID: 33840427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison.
    Giannini C; De Carlo M; Tamburino C; Ettori F; Latib AM; Bedogni F; Bruschi G; Presbitero P; Poli A; Fabbiocchi F; Violini R; Trani C; Giudice P; Barbanti M; Adamo M; Colombo P; Benincasa S; Agnifili M; Petronio AS
    Int J Cardiol; 2017 Sep; 243():126-131. PubMed ID: 28595747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, indications and predicting factors of permanent pacemaker implantation after transcatheter aortic valve implantation: A retrospective study.
    Becker M; Blangy H; Folliguet T; Villemin T; Freysz L; Luc A; Maureira P; Popovic B; Olivier A; Sadoul N
    Arch Cardiovasc Dis; 2017 Oct; 110(10):508-516. PubMed ID: 28647466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcathether aortic valve implantation with the new repositionable self-expandable Medtronic Evolut R vs. CoreValve system: evidence on the benefit of a meta-analytical approach.
    Kowalewski M; Gozdek M; Raffa GM; Słomka A; Zieliński K; Kubica J; Anisimowicz L; Kowalewski J; Landes U; Kornowski R; Lorusso R; Suwalski P
    J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):226-236. PubMed ID: 30829877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term pacemaker dependency after transcatheter aortic valve implantation.
    Schernthaner C; Kraus J; Danmayr F; Hammerer M; Schneider J; Hoppe UC; Strohmer B
    Wien Klin Wochenschr; 2016 Mar; 128(5-6):198-203. PubMed ID: 26745972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe conduction defects requiring permanent pacemaker implantation in patients with a new-onset left bundle branch block after transcatheter aortic valve implantation.
    Nijenhuis VJ; Van Dijk VF; Chaldoupi SM; Balt JC; Ten Berg JM
    Europace; 2017 Jun; 19(6):1015-1021. PubMed ID: 28340150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical Trial.
    Tamburino C; Bleiziffer S; Thiele H; Scholtz S; Hildick-Smith D; Cunnington M; Wolf A; Barbanti M; Tchetchè D; Garot P; Pagnotta P; Gilard M; Bedogni F; Van Belle E; Vasa-Nicotera M; Chieffo A; Deutsch O; Kempfert J; Søndergaard L; Butter C; Trillo-Nouche R; Lotfi S; Möllmann H; Joner M; Abdel-Wahab M; Bogaerts K; Hengstenberg C; Capodanno D
    Circulation; 2020 Dec; 142(25):2431-2442. PubMed ID: 33054367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.